These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 11178404

  • 1. Replacement of the Toxin Neutralisation Test in Mice by in vitro Serological Assay Systems for Potency Testing of Tetanus Toxoid Vaccines for Veterinary Use: Results of a European Collaborative Study.
    Hendriksen CF.
    ALTEX; 1994; 11(5):30-34. PubMed ID: 11178404
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Serological methods for potency testing of tetanus toxoid vaccines for human use.
    Hendriksen C, Winsnes R.
    Dev Biol (Basel); 2002; 111():131-40. PubMed ID: 12678232
    [Abstract] [Full Text] [Related]

  • 4. Validation of the toxin-binding inhibition (ToBI) test for the estimation of the potency of the tetanus toxoïd component in vaccines.
    van der Gun J, Akkermans A, Hendriksen C, van de Donk H.
    Dev Biol Stand; 1996; 86():199-206. PubMed ID: 8785949
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serological assays as alternatives to the Ph Eur challenge test for batch release of tetanus vaccines for human use.
    Winsnes R, Hendriksen C, Sesardic D, Akkermans A, Daas A.
    Dev Biol Stand; 1999; 101():277-88. PubMed ID: 10566802
    [Abstract] [Full Text] [Related]

  • 7. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines-part 1.
    Winsnes R, Sesardic D, Daas A, Behr-Gross ME.
    Pharmeuropa Bio; 2004 Jan; 2003(2):35-68. PubMed ID: 14960262
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Collaborative study for the establishment of two European Pharmacopoeia Biological Reference Preparations for serological potency testing of tetanus vaccines for veterinary use.
    Lensing HH, Behr-Gross ME, Daas A, Spieser JM.
    Dev Biol (Basel); 2002 Jan; 111():69-76. PubMed ID: 12678226
    [Abstract] [Full Text] [Related]

  • 10. Optimisation and establishing of serological methods for the potency testing of immunglobulins against Clostridium tetani-toxin.
    Ebert E, Abu Karim A, Kayser T, Wenig R, Weibetaer K, Wirz M, Pisani G, Schäffner G, Cubetaler K.
    ALTEX; 1998 Jan; 15(5):30-32. PubMed ID: 11178535
    [Abstract] [Full Text] [Related]

  • 11. Replacement of the in vivo neutralisation test for efficacy demonstration of tetanus vaccines ad us. vet.
    Rosskopf U, Noeske K, Werner E.
    ALTEX; 2005 Jan; 22(3):169-74. PubMed ID: 16186992
    [Abstract] [Full Text] [Related]

  • 12. Collaborative study for the validation of alternative in vitro potency assays for human tetanus immunoglobulin.
    Gross S, Janssen SW, de Vries B, Terao E, Daas A, Buchheit KH.
    Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):11-25. PubMed ID: 20144449
    [Abstract] [Full Text] [Related]

  • 13. Calibration of replacement international standard and European pharmacopoeia biological reference preparation for tetanus toxoid, adsorbed.
    Sesardic D, Winsnes R, Rigsby P, Tierney R, Gaines-Das R.
    Biologicals; 2002 Mar; 30(1):49-68. PubMed ID: 11846430
    [Abstract] [Full Text] [Related]

  • 14. Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for Clostridia antiserum for serological potency testing of veterinary clostridial vaccines.
    Lucken R, Daas A, Behr-Gross ME.
    Dev Biol (Basel); 2002 Mar; 111():171-80. PubMed ID: 12678238
    [Abstract] [Full Text] [Related]

  • 15. Development and prevalidation of alternative methods for the potency testing of C. perfringens vaccines.
    Ebert E, Öppling V, Werner E, Cubetaler K.
    ALTEX; 1998 Mar; 15(5):59-61. PubMed ID: 11178544
    [Abstract] [Full Text] [Related]

  • 16. [The use of the toxin binding inhibition test for potency testing of Clostridium novyi type B alpha toxoid vaccines].
    Luick K, Gottschaldt J, Schulze F, Werner E, Erler W, Borrmann E.
    Dtsch Tierarztl Wochenschr; 2002 Apr; 109(4):178-82. PubMed ID: 11998370
    [Abstract] [Full Text] [Related]

  • 17. Quantitation of tetanus and diphtheria antitoxins in mouse sera by indirect haemagglutination.
    Maheshwari SC, Sharma SB, Kumar A, Sokhey J.
    J Commun Dis; 1998 Mar; 30(1):23-8. PubMed ID: 9842161
    [Abstract] [Full Text] [Related]

  • 18. The use of the in vitro toxin binding inhibition (ToBI) test for the estimation of the potency of tetanus toxoid.
    Hendriksen CF, van der Gun JW, Marsman FR, Kreeftenberg JG.
    Biologicals; 1991 Jan; 19(1):23-9. PubMed ID: 2049173
    [Abstract] [Full Text] [Related]

  • 19. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines - extended study: correlation of serology with in vivo toxin neutralisation.
    Sesardic D, Winsnes R, Rigsby P, Behr-Gross ME.
    Pharmeuropa Bio; 2004 Jan; 2003(2):69-76. PubMed ID: 14960263
    [Abstract] [Full Text] [Related]

  • 20. Interlaboratory validation of in vitro serological assay systems to assess the potency of tetanus toxoid in vaccines for veterinary use.
    Hendrikson CF, Woltjes J, Akkermans AM, van der Gun JW, Marsman FR, Verschure MH, Veldman K.
    Dev Biol Stand; 1996 Jan; 86():335. PubMed ID: 8785975
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.